1.Risk factors of anastomotic stenosis after esophageal cancer surgery
Wenrong YANG ; Aimin LI ; Lijie YANG ; Zhonghua LI ; Zheng SONG ; Wanchun YANG ; Jianyuan CHA
China Modern Doctor 2025;63(23):24-27
Objective To investigate the risk factors for postoperative anastomotic stenosis in esophageal cancer patients.Methods A total of 200 patients who underwent radical esophageal cancer resection at the First Affiliated Hospital of Dali University from July 2015 to June 2024 were selected as subjects.The patients were divided into stenosis group(n=100)and non-stenosis group(n=100)based on whether they had benign anastomotic stenosis.Comparative analyses were conducted regarding the first feeding time,surgical duration,use of non-linear anastomotic devices,and anastomotic leakage in both groups.The independent risk factors for benign postoperative anastomotic stenosis were systematically evaluated.Results Delayed initial postoperative feeding,non-linear anastomotic devices,anastomotic leakage,and persistent postoperative hypoxemia were identified as risk factors for anastomotic stenosis in esophageal cancer patients after neck anastomosis.Balloon dilation-induced bleeding and early postoperative feeding within 12h served as protective factors(P<0.05).Conclusion The development of anastomotic stenosis in esophageal cancer patients following neck anastomosis may be associated with delayed initial feeding,non-linear anastomotic devices,anastomotic leakage,and persistent hypoxemia.
2.Network pharmacology and molecular docking analysis based on mechanism of Compound Gastritis Mixture in treatment of chronic atrophic gastritis
Qiuyue WANG ; Zhengning YANG ; Xiaofeng HUANG ; Minghan HUANG ; Wenrong WANG
Journal of Jilin University(Medicine Edition) 2025;51(3):691-702
Objective:To investigate the active ingredients and targets of Compound Gastritis Mixture(CGM)in the treatment of chronic atrophic gastritis(CAG)by network pharmacology method,and to validate the potential mechanism combined with molecular docking technology and cellular experiments.Methods:The Traditional Chinese Medicine System Analysis Platform(TCMSP)and Swiss Target Prediction databases were used to select the herbal ingredients of CGM and the corresponding targets;the GeneCards and Online Mendelian Inheritance in Man(OMIM)database were used to screen the targets of CAG;the common targets of CGM and CAG were analyzed from the Venny2.1.0 platform;STRING online platform was used to construct protein-protein interaction(PPI)networks for common drug-disease targets and screen the core targets.Cytoscape 3.9.1 software was used to construct the drug-disease-target network and screen the drug core components;Gene Ontology(GO)fuctional,Kyoto Encyclopedia of Genes and Genomes(KEGG)signaling pathway enrichment analysis were used to analyze the common targets of CGM and CAG;and AutoDock analysis software was used to perform molecular docking analysis of predicted main components of the drugs and core targets.The gastric mucosal epithelial cells GES-1 were induced by lipopolysaccharide(LPS)to construct CAG cell model.The GES-1 cells were divided into blank group(10%serum complete medium),model group(10 mg·L-1 LPS),and different concentrations of CGM groups(50,100,200,400,800 and 1 600 g·L-1 CGM+10 mg·L-1 LPS),and cells were incubated for 12,24,and 48 h.The cell counting kit-8(CCK-8)assay was used to detect the proliferation activities of GES-1 cells.The GES-1 cells were divided into blank group(10%serum complete medium),model group(10 mg·L-1 LPS)and CGM group(1 600 g·L-1 CGM+10 mg·L-1 LPS).Real-time fluorescence quantitative PCR(RT-qPCR)method was used to detect the expression levels of interleukin(IL)-6,tumor necrosis factor(TNF),serine/threonine protein kinase 1(AKT1),IL-1β,and epidermal growth factor receptor(EGFR)mRNA in the cells in various groups.Results:A total of 198 ingredients of CGM were screened,and 128 common targets with CAG were identified.The main herbal ingredients of CGM in treatment of CAG were quercetin,kaempferol,and lluteolin,which mainly acted on the core targets of IL-6,TNF,AKT1,IL-1β,and EGFR.The GO function enrichment analysis results showed that the top 15 targets mainly focused on biological processes(BP)such as apoptosis,inflammatory response and cell proliferation,mainly included cellular components(CC)such as cytoplasm,cell surface and macromolecular complexes,and mainly exerted molecular functions(MF)such as proteins,enzymes and ubiquitin-protein ligases.A total of 158 pathways were obtained from KEGG signaling pathway enrichment analysis,mainly involved cancer-related pathways,TNF signaling pathways,viral infection,programmed cell death-ligand 1(PD-L1)/programmed cell death protein-1(PD-1)pathways,apoptosis,NOD-like receptor signaling pathways,Toll-like receptor signaling pathways,EGFR,and IL-17 signaling pathways.The binding energies of the core targets IL-6,TNF,IL-1β,AKT1,and EGFR with main herbal ingredients quercetin,kaempferol,and luteolin were<-5 kcal·mol-1.The CCK-8 assay results showed that compared with blank group,after 24 and 48 h of cell culture,the proliferation activities of the cells in model group were significantly decreased(P<0.01),and the inhibition of the proliferation activity was more obvious after 48 h;therefore,48 h was selected for the modeling time;compared with model group,the proliferation activities of cells in 800 and 1 600g·L-1 GCM groups were significantly decreased(P<0.01),and the promotion of cell proliferation activity was more obvious in 1 600g·L-1 GCM group,so the intervening concentration of this drug was selected for the subsequent experiments.The RT-qPCR method results showed that compared with blank group,the expression levels of IL-6,TNF,IL-1β,AKT1,and EGFR mRNA in the cells in model group were significantly increased(P<0.01);compared with model group,the expression levels of IL-6,IL-1β,AKT1 and EGFR mRNA in the cells in CGM group were significantly decreased(P<0.01).Conclusion:CGM may play a role in the prevention and treatment of CAG through multiple ingredients such as quercetin,kaempferol and lignocerol,acting on the multiple target proteins such as IL-6,TNF,AKT1,IL-1β,and EGFR,as well as involving a variety of"inflammatory-cancer-related"pathways.
3.Risk factors of anastomotic stenosis after esophageal cancer surgery
Wenrong YANG ; Aimin LI ; Lijie YANG ; Zhonghua LI ; Zheng SONG ; Wanchun YANG ; Jianyuan CHA
China Modern Doctor 2025;63(23):24-27
Objective To investigate the risk factors for postoperative anastomotic stenosis in esophageal cancer patients.Methods A total of 200 patients who underwent radical esophageal cancer resection at the First Affiliated Hospital of Dali University from July 2015 to June 2024 were selected as subjects.The patients were divided into stenosis group(n=100)and non-stenosis group(n=100)based on whether they had benign anastomotic stenosis.Comparative analyses were conducted regarding the first feeding time,surgical duration,use of non-linear anastomotic devices,and anastomotic leakage in both groups.The independent risk factors for benign postoperative anastomotic stenosis were systematically evaluated.Results Delayed initial postoperative feeding,non-linear anastomotic devices,anastomotic leakage,and persistent postoperative hypoxemia were identified as risk factors for anastomotic stenosis in esophageal cancer patients after neck anastomosis.Balloon dilation-induced bleeding and early postoperative feeding within 12h served as protective factors(P<0.05).Conclusion The development of anastomotic stenosis in esophageal cancer patients following neck anastomosis may be associated with delayed initial feeding,non-linear anastomotic devices,anastomotic leakage,and persistent hypoxemia.
4.Phenotype and genotype of epilepsy patients related to CLCN4 variants
Wenrong ZHANG ; Ying YANG ; Miaomiao CHENG ; Ting WANG ; Changhao LIU ; Xiaoling YANG ; Yuehua ZHANG
Chinese Journal of Neurology 2024;57(9):968-974
Objective:To summarize the clinical phenotypes and genetic variations of children with epilepsy related to CLCN4 gene mutations. Methods:A retrospective analysis was conducted on 9 children with epilepsy who were diagnosed with CLCN4 gene mutations through whole-exome sequencing of family members. These children were treated at the Department of Pediatrics, Peking University First Hospital from December 2016 to March 2024. Their clinical manifestations, electroencephalogram, cranial imaging characteristics, and treatment follow-up were reviewed. Results:Among the 9 children, 6 were male and 3 were female. All cases involved de novo mutations. Three cases carried the c.823G>A/p.V275M variant, 2 cases carried the c.2152C>T/ p.R718W variant, 1 case carried the c.1630G>A/pG544R variant, and 1 case carried the c.2167C>T/ p.R723W variant. Two cases carried the unreported new variant c.848G>T/p.S283I and c.818G>A/ p.G273E. The onset age of epilepsy ranged from 55 days to 10 years, with a median onset age of 14 months. Seven out of 9 children had epilepsy onset before the age of 2 years. The types of seizures varied: 8 had focal seizures, 1 had generalized tonic-clonic seizures, 2 had myoclonic seizures, 1 had epileptic spasms, and 1 had atypical absence seizures. Three children experienced multiple types of seizures. All 9 children exhibited developmental delays to varying degrees: 8 had global developmental delay and 1 had cognitive developmental delay. Developmental delays were observed in 7 children before the onset of epilepsy. Clinically, 1 child was diagnosed with infantile epileptic spasms syndrome, 7 with unclassified developmental and epileptic encephalopathy, and 1 with focal epilepsy with developmental delay. At the last follow-up, the age of the children ranged from 2 years and 5 months to 13 years and 9 months. Seizures had been controlled in 3 children for a duration of 4 to 12 months. Conclusions:De novo variants are common in CLCN4 variants. Most seizures onset in infancy, seizure types are various, and focal seizures are common. Most of them have developmental delay and drug-resistant epilepsy, and some of them have developmental delay before seizure onset, which is consistent with the characteristics of developmental and epileptic encephalopathy.
5. Clinical characteristics of nonlesional temporal lobe epilepsy
Linmei YE ; Cong CHEN ; Fang DING ; Linglin YANG ; Bo JIN ; Shuang WANG
Chinese Journal of Neurology 2020;53(2):103-109
Objective:
To investigate the clinical characteristics, memory and neuroimaging features of nonlesional temporal lobe epilepsy (TLE-NL).
Methods:
Forty-four patients with TLE-NL and 53 patients with unilateral temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) were recruited from the Second Affiliated Hospital of Zhejiang University from September 1st 2012 to August 31st 2017. The clinical characteristics were systematically analyzed and compared between TLE-NL and TLE-HS. Twenty healthy volunteers were also recruited. Memory assessment and high resolution magnetic resonance imaging (MRI) scanning were completed in the patients and healthy volunteers. Volume and shape of the hippocampus were compared between patients and healthy volunteers.
Results:
Compared with the TLE-HS, TLE-NL patients showed later seizure onset ((24.3±12.6)
6.Risk factors of birth weight discordance in dichorionic diamniotic twin pregnancies: analysis of 1 757 cases
Xi CHEN ; Hong WANG ; Xiaotian LI ; Fanhua SHI ; Wenrong WANG ; Guichun DING ; Xiaoping FEI ; Xiahong WANG ; Meihua ZHANG ; Shufang YU ; Yang PENG ; Hongbo WU ; Xiaoyan CHENG
Chinese Journal of Perinatal Medicine 2020;23(10):695-701
Objective:To investigate the risk factors of birth weight discordance in dichorionic diamniotic (DCDA) twins.Methods:This study retrospectively analyzed 1 757 cases of DCDA twin pregnancies from 11 Chinese hospitals from January 1, 2014, to December 31, 2017. Birth weight discordance was defined as ≥ 20% difference between the twins. All cases were divided into two groups: the concordant group ( n=1 520) and discordant group ( n=237). General information was compared and the high-risk factors of birth weight discordance were analyzed. Mann-Whitney U test, Chi-square test or Fisher's exact test, and logistic regression analysis were used as statistical methods. Results:Compared with the concordant group, the discordant group showed a higher incidence of hypertensive disorders of pregnancy [24.5% (58/237) vs 12.8% (194/1 520), χ2=22.882, P<0.05], fetal structural malformations [4.2% (10/237) vs 1.0% (15/1 520), χ2=15.160, P<0.05], fetal distress [6.3% (15/237) vs 1.4% (21/1 520), χ2=22.602, P<0.05], umbilical cord abnormalities [3.8% (9/237) vs 1.2% (18/1 520), χ2=7.607, P<0.05] and abnormal placental cord insertion [3.8% (9/237) vs 1.4% (21/1 520), χ2=34.904, P<0.05], but lower incidence of premature rupture of membranes [11.0% (26/237) vs 16.5% (250/1 520), χ2=4.645, P=0.034]. Logistic regression analysis showed that the independent risk factors of birth weight discordance in DCDA twins were hypertensive disorders of pregnancy ( OR=2.258, 95% CI: 1.620-3.184, P<0.001), fetal structural malformations ( OR=4.268, 95% CI: 1.892-9.631, P<0.001), umbilical cord abnormalities ( OR=2.889, 95% CI: 1.245-6.705, P=0.014) and abnormal placental cord insertion ( OR=2.318, 95% CI: 1.012-5.311, P=0.047). Conclusions:Hypertensive disorders of pregnancy, fetal structural malformations, umbilical cord abnormalities and abnormal placental cord insertion may be the risk factors of birth weight discordance in DCDA twins.
7.Evidenced-based Evaluation of Personnel Training Mode in Pharmacy Intravenous Admixture Services in China
Chunsong YANG ; Lingli ZHANG ; Yunzhu LIN ; Lu HAN ; Yeli WANG ; Shan GAO ; Wenrong JIN
China Pharmacy 2019;30(5):708-711
OBJECTIVE: To systematically evaluate the mode of personnel training in pharmacy intravenous admixture services (PIVAS) in China, and to provide reference for the comprehensive training of pharmacist in PIVAS in China. METHODS: PubMed, Embase, Cochrane Library, CBM, CJFD, VIP and Wanfang database were searched from the establishment of database to Sept. 2018. Studies which evaluated the training mode of PIVAS in China were included, and the results were presented by descriptive analysis in respects of training objects, training objectives, contents and evaluation indicators. RESULTS: A total of 5 literatures were included. The research types were 2 before-after control studies, 2 experience sharing studies and 1 review. 3 subjects were pharmacists, 1 subject was clinical pharmacists, and 1 subject was nurses. The training objectives were comprehensive quality training, clinical rational drug use level, pharmacy personnel training path and professional service ability. The specific training content of the training mode varied greatly, including professional theoretical knowledge, practical operation ability, pre-job training, professional psychological quality, professional ethics and laws and regulations, continuing education learning ability, career development planning and teaching ability. There were great differences in the evaluation indicators of training effectiveness, which were mainly reflected in team execution motivation and creativity, discoveny rate of unreasonable doctor’s advice, work efficiency, service quality, drug treatment level and satisfaction of PIVAS, etc. CONCLUSIONS: There are certain differences in the training objectives, training targets, specific contents and evaluation indicators of the PIVAS pharmacist training model in China. It is necessary to use the evidence- based method to construct the training mode for PIVAS pharmacist to provide support for clinical intravenous drug use.
8.Systematic Evaluation of Current Status of Charges in PIVAS of China
Chunsong YANG ; Tianyi ZHANG ; Lingli ZHANG ; Yunzhu LIN ; Lu HAN ; Yeli WANG ; Shan GAO ; Wenrong JING
China Pharmacy 2019;30(17):2414-2418
OBJECTIVE: To systematically evaluate current status of charges in pharmacy intravenous admixture services (PIVAS), and to provide reference for the formulation of China’s pharmacy intravenous admixture services (PIVAS) charging standards. METHODS: Retrieved from PubMed, Embase, Cochrane library, CBM, CNKI, VIP, Wanfang database and related goverment websets, the literatures about current status evaluation of charges in PIVAS of China were collected during the establishment of database to Jan. 2019. Cost estimation, charge standard, influential factors and other indicators were collected, and the results were presented by descriptive analysis. RESULTS: A total of 5 literatures were included, all of which were reviewed. According to the existing literatures, except for Shandong, Guangdong and Yunnan provinces, there were no regional charge standards in other provinces (districts and cities). The cost estimation methods of PIVAS in these three provinces were basically the same. The cost could be obtained by adding up the business fees, labor fees, fees of medical instruments purchase and use, indirect fees etc. Dispensing charges in PIVAS were 3-5 yuan per piece for general drug, 5 yuan per piece for antibiotics and 8-12 yuan per piece for cancer chemotherapeutics, 20-35 yuan per piece for TPN. The charging level was mainly affected by local prices, PIVAS scale, hardware investment, management and other factors. CONCLUSIONS: There is no unified charging standard for PIVAS in most provinces (districts, cities) of China. The cost estimation methods of the hospitals from the included literatures are basically the same. It is necessary to construct national PIVAS charging standard and cost estimation method, which could provide a basis for formulating the price of medical and health services.
9.Status Quo of Cost Estimation and Systematic Review in Pharmacy Intravenous Admixture Services in China
Chunsong YANG ; Tianyi ZHANG ; Lingli ZHANG ; Yunzhu LIN ; Lu HAN ; Yeli WANG ; Shan GAO ; Wenrong JIN
China Pharmacy 2019;30(19):2707-2711
OBJECTIVE: To systematically evaluate the status quo of cost estimation in pharmacy intravenous admixture services (PIVAS), and to provide cost basis for the construction of PIVAS in China. METHODS: Retrieved from PubMed, Embase, Cochrane library, CBM, CNKI, CSJD and Wanfang database from database establishment to Jan. 2019, the studies about the status quo of cost estimation in PIVAS of China were included. The descriptive analysis was conducted for content and method of cost estimation, infection to hospital. RESULTS: A total of 17 literatures were included, involving 8 before and after control studies, 6 experience sharing studies and 3 reviews. Existing reports showed that the estimation contents and methods of PIVAS cost were roughly the same. The cost included manpower, medical and health materials, fixed asset purchase, depreciation, repair costs, medicine cost and indirect costs. At the same time, the infection to hospital were reported, such as in manpower adopting, formulating detailed management measures and systems, concurrent allocation of the same kind of drugs, shortening infusion preparation and replacement time, in order to save manpower cost. CONCLUSIONS: PIVAS cost calculation method is roughly the same in some hospitals, but there is no uniform standard. It is necessary to further improve the PIVAS cost measurement standard and provide a basis for the construction and development of PIVAS in China.
10. Progress of relation between melatonin and epilepsy
Lin WAN ; Wenrong GE ; Guang YANG
Chinese Journal of Applied Clinical Pediatrics 2019;34(21):1671-1674
Epilepsy is a common disease of the central nervous system.Previous studies have shown that it is associated with circadian rhythm, however, the exact mechanism of action is still unknown.Currently, it has been proved by a lot of evidences that the secretion of melatonin is regulated by circadian rhythm, as well as the expression level of melatonin can feedback and regulate circadian rhythm.The relationship between melatonin and epilepsy is closely rela-ted.Its anticonvulsive effect has been proved in a number of basic experiments.Simultaneously the serum concentration of melatonin in epileptic patients is significantly lower than that in general population.The frequency of seizure in the epileptic model mice are significantly reduced, after preconditioning with melatonin.However, the anticonvulsant effect of melatonin in the related clinical trials is not clear.This article mainly introduces the current research progress of the relationship between melatonin and epilepsy, and summarizes the related experimental results and the mechanism of action.

Result Analysis
Print
Save
E-mail